» Articles » PMID: 31997536

Phospho-inositide-dependent Kinase 1 Regulates Signal Dependent Translation in Megakaryocytes and Platelets

Overview
Publisher Elsevier
Specialty Hematology
Date 2020 Jan 31
PMID 31997536
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Regulated protein synthesis is essential for megakaryocyte (MK) and platelet functions, including platelet production and activation. PDK1 (phosphoinositide-dependent kinase 1) regulates platelet functional responses and has been associated with circulating platelet counts. Whether PDK1 also directly regulates protein synthetic responses in MKs and platelets, and platelet production by MKs, remains unknown.

Objective: To determine if PDK1 regulates protein synthesis in MKs and platelets.

Methods: Pharmacologic PDK1 inhibitors (BX-795) and mice where PDK1 was selectively ablated in MKs and platelets (PDK1 ) were used. PDK1 signaling in MKs and platelets (human and murine) were assessed by immunoblots. Activation-dependent translation initiation and protein synthesis in MKs and platelets was assessed by probing for dissociation of eIF4E from 4EBP1, and using m7-GTP pulldowns and S methionine incorporation assays. Proplatelet formation by MKs, synthesis of Bcl-3 and MARCKs protein, and clot retraction were employed for functional assays.

Results: Inhibiting or ablating PDK1 in MKs and platelets abolished the phosphorylation of 4EBP1 and eIF4E by preventing activation of the PI3K and MAPK pathways. Inhibiting PDK1 also prevented dissociation of eIF4E from 4EBP1, decreased binding of eIF4E to m7GTP (required for translation initiation), and significantly reduced de novo protein synthesis. Inhibiting PDK1 reduced proplatelet formation by human MKs and blocked MARCKs protein synthesis. In both human and murine platelets, PDK1 controlled Bcl-3 synthesis. Inhibition of PDK1 led to complete failure of clot retraction in vitro.

Conclusions: PDK1 is a previously unidentified translational regulator in MKs and platelets, controlling protein synthetic responses, proplatelet formation, and clot retraction.

Citing Articles

Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential.

Wurtzel J, Lazar S, Askari S, Zhao X, Severa J, Ayombil F Blood Adv. 2024; 8(6):1550-1566.

PMID: 38163324 PMC: 10982986. DOI: 10.1182/bloodadvances.2023011734.


Genetically engineered transfusable platelets using mRNA lipid nanoparticles.

Leung J, Strong C, Badior K, Robertson M, Wu X, Meledeo M Sci Adv. 2023; 9(48):eadi0508.

PMID: 38039367 PMC: 10691771. DOI: 10.1126/sciadv.adi0508.


Role of Nitric Oxide in Megakaryocyte Function.

Asgari A, Jurasz P Int J Mol Sci. 2023; 24(9).

PMID: 37175857 PMC: 10179655. DOI: 10.3390/ijms24098145.


A New Role of NAP1L1 in Megakaryocytes and Human Platelets.

Freitag M, Schwertz H Int J Mol Sci. 2022; 23(23).

PMID: 36499021 PMC: 9737020. DOI: 10.3390/ijms232314694.


MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis.

Manne B, Campbell R, Bhatlekar S, Ajanel A, Denorme F, Portier I Blood. 2022; 140(23):2477-2489.

PMID: 35930749 PMC: 9918849. DOI: 10.1182/blood.2022015568.


References
1.
Patel P, Golla K, Naik U . PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: comment. J Thromb Haemost. 2018; 16(9):1901-1904. PMC: 6159878. DOI: 10.1111/jth.14232. View

2.
Li D, Mullinax J, Aiken T, Xin H, Wiegand G, Anderson A . Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. BMC Cancer. 2018; 18(1):772. PMC: 6069886. DOI: 10.1186/s12885-018-4690-1. View

3.
Luo D, Xu X, Li J, Chen C, Chen W, Wang F . The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma. Int J Oncol. 2018; 53(5):2067-2080. DOI: 10.3892/ijo.2018.4525. View

4.
Luff S, Papoutsakis E . Megakaryocytic Maturation in Response to Shear Flow Is Mediated by the Activator Protein 1 (AP-1) Transcription Factor via Mitogen-activated Protein Kinase (MAPK) Mechanotransduction. J Biol Chem. 2016; 291(15):7831-43. PMC: 4824992. DOI: 10.1074/jbc.M115.707174. View

5.
Carriere A, Ray H, Blenis J, Roux P . The RSK factors of activating the Ras/MAPK signaling cascade. Front Biosci. 2008; 13:4258-75. DOI: 10.2741/3003. View